PROM1 and lip and oral cavity carcinoma: Additionally, it was found that using lentivirus transfection to silence CD133 in oral squamous cell carcinoma could help decrease the therapy resistance of oral cancer significantly.26 Although no clinical studies have been conducted on targeting CSC markers in combination with radiotherapy in oral cancer, the studies mentioned above have provided us with good insight.